Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Zoledronic Acid on Femoral Bone Loss Following Total Hip Arthroplasty

NCT01267279 is registered in ClinicalTrials.gov with Spokane Joint Replacement Center as lead sponsor.

NCT NCT01267279
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01267279 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Zoledronic Acid on Femoral Bone Loss Following Total Hip Arthroplasty
Lead sponsor
Spokane Joint Replacement Center
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2005
Completion date
December 31, 2014
Enrollment
51 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

osteoporosis